Posted On: 09/01/2014 9:34:22 AM
Post# of 30066
I've decided to vote YES
- while I would like nothing more than to see greater substantial milestone accomplished / publicised before the ASM, timelines are forever changing, especially in the startup biotech arena. It basically comes down to a couple of considerations, to name a just few:
trust
performance
management
BOD/BOA
competancy
vision
inventory
delivery
execution
I've had numerous opportunities to pull and sell my 2-Mil. shares with a substantial net gain, but decided long ago to remain "all in." I see no sound reason now to change my mind. If anything, I'm more convinced than ever AMBS is a burgeoning biotech superstar in the making.
All the Best, JP
- while I would like nothing more than to see greater substantial milestone accomplished / publicised before the ASM, timelines are forever changing, especially in the startup biotech arena. It basically comes down to a couple of considerations, to name a just few:
trust
performance
management
BOD/BOA
competancy
vision
inventory
delivery
execution
I've had numerous opportunities to pull and sell my 2-Mil. shares with a substantial net gain, but decided long ago to remain "all in." I see no sound reason now to change my mind. If anything, I'm more convinced than ever AMBS is a burgeoning biotech superstar in the making.
All the Best, JP
(0)
(0)
